Zydus Cadila gets USFDA nod to market acne drug

| | New Delhi
  • 0

Zydus Cadila gets USFDA nod to market acne drug

Sunday, 30 December 2018 | PTI | New Delhi

Drug firm Zydus Cadila Saturday said it has received final nod from the US health regulator to market Clindamycin Phosphate and Benzoyl Peroxide gel, used in the treatment of acne.

This combination medication is used to treat a certain type of acne (inflammatory acne vulgaris), the company said in a BSE filing. It also helps to decrease the number of acne pimples.

“Zydus Cadila has received the final approval from the USFDA to market Clindamycin Phosphate and Benzoyl Peroxide Gel, (US RLD —DUAC® Gel), 1.2 per cent/5 per cent.

“It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad,” it added.

Clindamycin is an antibiotic that stops the growth of acne-causing bacteria. Benzoyl peroxide can also stop the growth of bacteria as well as reduce oil production in the skin, it further said.

Sunday Edition

Links Hanuman to Dalits

14 April 2019 | PTI | Sunday Pioneer

Prashant Kishor rubbishes Rabri's merger bid claim

14 April 2019 | PTI | Sunday Pioneer

513 ceasefire violations by Pak post Balakot strike: Army

14 April 2019 | PTI | Sunday Pioneer

Sadiq Batcha’s wife wants his death re-probed

14 April 2019 | Kumar Chellappan | Sunday Pioneer

TN: EC seizes over `552 crore unaccounted cash, jewellery

14 April 2019 | PTI | Sunday Pioneer